David Tepper increased his stake in Chinese stocks like Alibaba, JD.com, and Baidu in Q4. His trades came right before the ...

The acquisition of Ambry Genetics strengthens Tempus AI's genomics capabilities by adding a West Coast lab and expanding ...

Completing its initial public offering on June 14, Tempus AI stock closed at $40.25, and while it rose above this mark from time to time in the second half of 2024, the stock ended the year on a sour ...

Cathie Wood doubled down on Tempus AI, despite the fact that TEM stock erased most of the gains made in the past month.

CompanyOverview|NASDAQ:TEM] Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results, presenting a buying ...

DeepSeek is a stark reminder about the importance of strategic durability, and not just growth or growth potential, to a ...

We recently published a list of 10 AI Stocks on Analysts’ Radar As AI Spending Grows. In this article, we are going to take a ...

Tempus posted a fourth-quarter adjusted net loss of $0.18 per share, $0.02 more per share than estimates by analysts surveyed by Visible Alpha. Revenue jumped 36% year-over-year to $200.7 million, but ...

Despite filing a fourth-quarter and yearend 2024 earnings report that the CEO described as "fantastic" yesterday afternoon, ...

The shift follows the DeepSeek breakthrough that showed it’s possible to reduce the amount of resources needed to run large ...

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...